Fidelity Investments
GCTK icon

Fidelity Investments’s GlucoTrack GCTK Stock Holding History

Fidelity Investments’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21
Closed -$128 – 5455
2025
Q2 		$128 Buy
+21
New +$184 ﹤0.01% 5121

Other funds holding GCTK

AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fidelity Investments's GCTK Position: Q3 2025 in Review

Fidelity Investments sold out of GlucoTrack (GCTK) in Q3 2025, closing a stake of 21 shares — an estimated $128 sold.

Fidelity Investments first reported a position in GCTK in Q2 2025 and held it in 1 quarter. The position peaked at $128 in Q2 2025. 8 funds tracked by Wall St. Rank hold GCTK as of Q3 2025.

  • Fidelity Investments reported no remaining GlucoTrack position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 21 GlucoTrack shares in Q3 2025, an estimated $128.
  • Fidelity Investments first reported a position in GlucoTrack in Q2 2025 and held it in 1 quarter.
  • Fidelity Investments's GlucoTrack position peaked at $128 in Q2 2025.
  • 8 funds tracked by Wall St. Rank held GlucoTrack as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.